Skip to main content
The Globe and Mail
Support Quality Journalism.
The Globe and Mail
First Access to Latest
Investment News
Collection of curated
e-books and guides
Inform your decisions via
Globe Investor Tools
Just$1.99
per week
for first 24 weeks

Enjoy unlimited digital access
Cancel Anytime
Enjoy Unlimited Digital Access
Get full access to globeandmail.com
Just $1.99per week for the first 24weeks
Just $1.99per week for the first 24weeks
var select={root:".js-sub-pencil",control:".js-sub-pencil-control",open:"o-sub-pencil--open",closed:"o-sub-pencil--closed"},dom={},allowExpand=!0;function pencilInit(o){var e=arguments.length>1&&void 0!==arguments[1]&&arguments[1];select.root=o,dom.root=document.querySelector(select.root),dom.root&&(dom.control=document.querySelector(select.control),dom.control.addEventListener("click",onToggleClicked),setPanelState(e),window.addEventListener("scroll",onWindowScroll),dom.root.removeAttribute("hidden"))}function isPanelOpen(){return dom.root.classList.contains(select.open)}function setPanelState(o){dom.root.classList[o?"add":"remove"](select.open),dom.root.classList[o?"remove":"add"](select.closed),dom.control.setAttribute("aria-expanded",o)}function onToggleClicked(){var l=!isPanelOpen();setPanelState(l)}function onWindowScroll(){window.requestAnimationFrame(function() {var l=isPanelOpen(),n=0===(document.body.scrollTop||document.documentElement.scrollTop);n||l||!allowExpand?n&&l&&(allowExpand=!0,setPanelState(!1)):(allowExpand=!1,setPanelState(!0))});}pencilInit(".js-sub-pencil",!1); // via darwin-bg var slideIndex = 0; carousel(); function carousel() { var i; var x = document.getElementsByClassName("subs_valueprop"); for (i = 0; i < x.length; i++) { x[i].style.display = "none"; } slideIndex++; if (slideIndex> x.length) { slideIndex = 1; } x[slideIndex - 1].style.display = "block"; setTimeout(carousel, 2500); } //

Tilray Inc NASDAQ: TLRY-Q

Today's Change
Volume
Real-Time Last Update Last Sale Cboe BZX Real-Time

Today's Trading

Day Low 18.88
Day High 20.30
Open:19.90
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.

More stories below advertisement

Description
Tilray, Inc. is a pharmaceutical company. It develops cannabis based medicines, drugs, drops and oil products. Tilray, Inc. is based in NANAIMO, Canada.

Fundamentals

Market Capitalization, $M
Shares Outstanding, M
36-Month Beta
Earnings Per Share (TTM)
Revenue Growth YoY
Profit Margin
5-Year Avg. Revenue Growth
5-Year Avg. Profit Growth
1-Year Total Return
3-Year Total Return
5-Year Total Return
Price/Earnings (TTM)
Price/Earnings (Forward)
Trailing Annual Dividend & Yield
Forward Annual Dividend & Yield
Most Recent Dividend
Ex-Div Date
Most Recent Split
Return on Common Equity
Return-on-Assets (Before Tax)
Debt-to-Equity Ratio
Price/Book

Earnings

Corporate earnings are provided from Zacks Investment Research, including Income Statements, Balance Sheets, Cash Flow Statements, and Statement of Retained Earnings.

Analyst Research

Analyst Ratings and Earnings Estimates are provided by Zacks Investment Research.

Moderate Buy

StockReports+

A premium report that provides detailed quantitative assessments of earnings, fundamentals, relative valuation, risk, price momentum and more. For subscribers only.

StockCalc

What is this stock worth in intrinsic value? View this premium StockCalc report to see this stock's valuation and how it was calculated using fundamental analysis. For subscribers only.

ValuEngine

A stock valuation and forecasting report include rating, fair value assessment, return forecasts, market ratio-based valuations and comparable analysis. Available for free with registration.

Latest Press Releases

Thinking about trading options or stock in Embraer, Boeing, Signet Jewelers, Tilray, or Micron Technology?
- PR Newswire - PRF - Thu Jun 10, 9:55AM CDT
PR Newswire - PRF - CMTX
Thu Jun 10, 9:55AM CDT
/PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ERJ, BA, SIG, TLRY, and MU.
Advancing Medical R&D for Cannabinoid Medicinal Uses Identifying Growing Number of Health Benefits
- PR Newswire - PRF - Thu Jun 10, 7:30AM CDT
PR Newswire - PRF - CMTX
Thu Jun 10, 7:30AM CDT
/PRNewswire/ -- Cannabidiol (CBD) extract is a product that's derived from cannabis. It's a type of cannabinoid, which are the chemicals naturally found in marijuana plants. Even though it comes from marijuana plants, CBD doesn't create a "high" effect or any form of intoxication — that's caused by another cannabinoid, known as THC. CBD is extracted from marijuana plants as either an oil or powder. These can be mixed into creams or gels. They can be put into capsules and taken orally, inhaled or rubbed on your skin. The multiple sclerosis drug nabiximols is sprayed as a liquid into your mouth. How CBD should be used depends largely on what it's being used for. There's some controversy around cannabis products like CBD oil because of recreational marijuana use. But there's growing awareness about the possible health benefits of CBD oil. An  in Healthline.com published what you need to know about several potential medical uses of CBD and where the research stands. It highlighted Anxiety Relief, Anti-seizure, Neuroprotective, Pain relief and Cancer. CBD may be able to help manage anxiety. Studies have shown that CBD may help relieve anxiety by: reducing stress, decreasing physiological effects of anxiety, such as an increased heart rate; improving symptoms of post-traumatic stress disorder (PTSD); and inducing sleep in cases of insomnia. CBD has also been in the news before, as a possible treatment for epilepsy. Research is still in its early days. Researchers are testing how much CBD is able to reduce the number of seizures in people with epilepsy, as well as how safe it is. Active Companies active today in the cannabis related markets include:  (NASDAQ: TLRY) (TSX: TLRY), (OTCPK: RTSL), (NASDAQ: CRON) (TSX: CRON), (NASDAQ: ZYNE), (NYSE: IGC).
Is Cannabis the Next Meme Stock Trader Target? (SGMD, TLRY, CGC, SNDL, GRWG, ACB)
- OTC - Thu Jun 10, 7:28AM CDT
OTC - CMTX
Thu Jun 10, 7:28AM CDT
The so-called "Meme Stock" revolution is upon us. Retail investors and social media trading "gangs" are ganging up on institutional hedge fund shorts and bears with massive implications for the publicly traded stock market.
Price History Describes more index sector components

Price Performance

Period Period Low Period High Performance
1-Month 13.75 +39.35% increase
on 05/17/21
Period Open:13.93
Price movement based on the high, low and last over the given period.
23.04 -16.84% decrease
on 06/09/21
+5.23 (+37.54%) increase
since 05/14/21
3-Month 13.41 +42.88% increase
on 05/13/21
Period Open:27.57
Price movement based on the high, low and last over the given period.
31.34 -38.86% decrease
on 03/15/21
-8.41 (-30.50%) decrease
since 03/12/21
52-Week 4.41 +334.47% increase
on 09/24/20
Period Open:8.42
Price movement based on the high, low and last over the given period.
67.00 -71.40% decrease
on 02/10/21
+10.74 (+127.55%) increase
since 06/12/20

More stories below advertisement

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2021.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

© 2021 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies